Michael is an experienced leader and innovator with a focus on the successful commercialisation of emerging technologies. Since joining Rhinomed in 2013, he has been responsible for the development of Rhinomed’s nasal technology platform and steering RhinoMed to being one of the world’s leading developers of wearable nasal medical technology. The company has now brought four products to market in the global sleep and snoring, respiratory and nasal congestion markets and is developing applications in the diagnostic and drug delivery markets. Over the course of his career he worked for a wide spectrum of companies from large multinationals through to start-up companies in Life Sciences, Cleantech, Financial Services and advertising and communication industries. Michael received a Master’s in Entrepreneurship and Innovation from Swinburne University and a Bachelor’s degree in Business from Monash University. Michael is a non-executive director of the US based Foundation for Airway Health